nelfinavir has been researched along with Acquired Immune Deficiency Syndrome in 55 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 21 (38.18) | 18.2507 |
| 2000's | 28 (50.91) | 29.6817 |
| 2010's | 5 (9.09) | 24.3611 |
| 2020's | 1 (1.82) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Dumond, JB; Fiscus, SA; Horton, AL; Kashuba, AD; Patterson, KB; Rezk, NL; Tappouni, HL; Tien, HC; Vourvahis, M; Yeh, RF | 1 |
| Bihani, SC; Gupta, GD; Hosur, MV | 1 |
| Alobwede, SM; Kongnyuy, EJ; Shey, MS; Wiysonge, CS | 1 |
| Almeida, SE; Antunes, DA; de Medeiros, RM; Junqueira, DM; Rigo, MM; Sinigaglia, M; Vieira, GF | 1 |
| Anderson, AM; Coffie, PA; Dabis, F; Eholie, SP; Ekouevi, DK; Gottlieb, GS; Tchounga, BK; Tegbe, J; Vitoria, M | 1 |
| Kongnyuy, EJ; Shang, J; Shey, M; Wiysonge, CS | 1 |
| Chandrasekar, S; Jayakanthan, M; Mathur, PP; Muthukumaran, J | 1 |
| Canter, JA; Grady, BJ; Haas, DW; Hulgan, T; Kalams, SA; Murdock, DG; Pollard, RB; Ritchie, MD; Robbins, GK; Samuels, DC; Selph, D; Shafer, R | 1 |
| Carr, A; Chisholm, DJ; Cooper, DA; Gan, SK; Kraegen, EW; Samaras, K; Thompson, CH | 1 |
| Bennett, KK; Hammer, SM; Labbé, L; Mellors, J; Pfister, M; Rosenkranz, S; Sheiner, LB | 1 |
| Ait-Khaled, M; Babiker, AG; Compagnucci, A; De Rossi, A; Dunn, DT; Gibb, DM; Kaye, S; Loveday, C; Muñoz-Fernandez, MA; Pillay, D; Walker, AS | 1 |
| Aweeka, FT; Floren, LC; Hayashi, S; Jayewardene, A; Johnson, G; Krogstad, P; Nachman, S; Stanley, K; Wiznia, A | 1 |
| Bassett, R; Currier, JS; DeGruttola, V; Demeter, LM; Eron, JJ; Fischl, MA; Hammer, SM; Mellors, JW; Morse, GD; Santana, JL; Squires, KE | 1 |
| Demeter, LM; Erice, A; Eshleman, SH; Fischl, MA; Hammer, SM; Hellmann, NS; Ribaudo, HJ | 1 |
| Carosi, G; Casari, S; Moretti, F; Quiros-Roldan, E; Tirelli, V; Torti, C | 1 |
| Brunet, M; Gallart, T; García, F; Gatell, JM; Martorell, J; Millán, O; Miró, JM; Plana, M; Pumarola, T; Rojo, I; Vidal, E | 1 |
| Antinori, A; Baxter, J; Cauda, R; Clevenbergh, P; Colafigli, M; De Luca, A; Giambenedetto, SD; Perno, CF; Prosperi, M; Ruiz, L; Trotta, MP | 1 |
| Kuritzkes, DR; McDonald, CK | 1 |
| Cao, Y; Ho, DD; Markowitz, M; Saksela, K; Vesanen, M | 1 |
| Ferrando, S; Rabkin, JG | 1 |
| Krause, KL; Musher, DM; Visnegarwala, F | 1 |
| Grodesky, MJ; Klaus, BD | 1 |
| Chiba, N; Hayashi, H; Shintani, M; Ueno, T | 1 |
| Cammack, N; Dalgleish, AG; Sharland, M; Watkins, AM; Westby, M | 1 |
| Cao, Y; Chapman, S; Duran, M; Keller, MR; Knowles, M; Kuritzkes, DR; Markowitz, M; Mazabel, E; Patick, AK; Shugarts, D | 1 |
| Aweeka, F; Bellibas, SE; Jayewardene, A; Kearney, B; Lizak, P; Novakovic-Agopian, T; Price, RW; Staprans, S | 1 |
| Furrer, H; Malinverni, R | 1 |
| Bonhoeffer, S; Hellmann, N; Ho, DD; Lie, YS; Markowitz, M; Parkin, NT; Petropoulos, CJ | 1 |
| Matsumura, Y; Takada, K; Yamaji, H; Yoshikawa, Y | 1 |
| Elmadfa, I; Jilma, B; Parschalk, B; Pernerstorfer-Schoen, H; Schindl, A; Schindler, K; Thoeny-Lampert, S; Tschachler, E; Wunderer, K | 1 |
| Heinrikson, RL; Tomasselli, AG | 1 |
| Hart, AA; Hoetelmans, RM; Lange, JM; Mulder, JW; Reijers, MH; Reiss, P; Schuitemaker, H; Ten Kate, RW; Weigel, HM; Weverling, GJ | 1 |
| Beguinot, I; Bernard, P; Derancourt, C; Drobacheff, C; Verraes, S | 1 |
| Bakker, A | 1 |
| Elmadfa, I; Pernerstorfer-Schoen, H; Rieger, A; Schindler, K; Schneider, B | 1 |
| Abeli, C; Adorni, F; Bini, T; Bongiovanni, M; Castelnuovo, B; Chiesa, E; d'Arminio Monforte, A; Melzi, S; Sollima, S; Testa, L | 1 |
| Airoldi, M; Carosi, G; Castelli, F; Patroni, A; Quiros-Roldan, E; Signorini, S; Torti, C | 1 |
| Bode, H; Fromm, M; Riecken, EO; Schmidt, W; Schulzke, JD; Ullrich, R | 1 |
| Levin, J | 1 |
| Burger, DM; Chesney, MA; Danner, SA; de Wolf, F; Hoetelmans, RM; Hugen, PW; Jambroes, M; Kauffmann, RH; Lange, JM; Meenhorst, PL; Nieuwkerk, PT; Schneider, MM; Schrey, G; Sprangers, MA; Sprenger, HG; van Der Ende, ME | 1 |
| de Boer, J | 1 |
| Craig, C; Perrin, L; Popescu, M; Rickenbach, M; Taffe, P; Yerly, S | 1 |
| Ahmad, K | 1 |
| Johnson, GM; Krogstad, PA; Lee, S; Mohan, K; Morse, EV; Nachman, S; Stanley, K; Van Dyke, RB; Wiznia, A | 1 |
| Goodsell, DS; Morris, GM; Olson, AJ; Sanner, MF; Stoffler, D | 1 |
8 review(s) available for nelfinavir and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Combinations; HIV Infections; Humans; Lamivudine; Nelfinavir; Oligopeptides; Pyridines; Randomized Controlled Trials as Topic; Zidovudine | 2013 |
Antiretroviral therapy response among HIV-2 infected patients: a systematic review.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Female; HIV Infections; HIV-2; Humans; Indinavir; Lopinavir; Male; Middle Aged; Nelfinavir; Ritonavir; Treatment Outcome | 2014 |
A combination drug of abacavir-lamivudine-zidovudine (Trizivir) for treating HIV infection and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Drug Combinations; HIV Infections; Humans; Lamivudine; Nelfinavir; Oligopeptides; Pyridines; Randomized Controlled Trials as Topic; Zidovudine | 2009 |
Human immunodeficiency virus type 1 protease inhibitors.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Interactions; Drug Resistance; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoquinolines; Nelfinavir; Ritonavir; RNA, Viral; Saquinavir; Sulfonic Acids | 1997 |
A 'second life' agenda. Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Attitude to Health; Drug Approval; Drug Costs; Drug Interactions; Health Policy; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Life Style; Nelfinavir; Primary Prevention; Ritonavir; Saquinavir; United States; United States Food and Drug Administration; Viral Load | 1997 |
[Clinical application of HIV protease inhibitors].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; HIV Protease Inhibitors; HIV Reverse Transcriptase; Humans; Indinavir; Nelfinavir; Ritonavir; Saquinavir | 1998 |
Targeting the HIV-protease in AIDS therapy: a current clinical perspective.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Binding Sites; Carbamates; Clinical Trials as Topic; Computer-Aided Design; Crystallography, X-Ray; Drug Design; Drug Resistance, Microbial; Drug Therapy, Combination; Furans; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Nelfinavir; Oligopeptides; Pyridines; Pyrones; Randomized Controlled Trials as Topic; Ritonavir; Saquinavir; Sulfonamides | 2000 |
[Early treatment of sexual exposure to human immunodeficiency virus].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Combinations; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Nelfinavir; Probability; Risk Factors; Sexual Behavior; Sexual Partners; Time Factors; Zidovudine | 2000 |
11 trial(s) available for nelfinavir and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Base Sequence; Benzoxazines; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cyclopropanes; Drug Therapy, Combination; Female; Genome, Mitochondrial; Haplotypes; Humans; Male; Middle Aged; Molecular Sequence Data; Nelfinavir; Polymorphism, Single Nucleotide; RNA, Viral; Treatment Outcome; Viral Load; Young Adult | 2011 |
Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: Adult AIDS Clinical Trial Group Study 398.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Bayes Theorem; Benzoxazines; Cyclopropanes; Drug Interactions; Female; HIV Protease Inhibitors; Humans; Indinavir; Male; Models, Biological; Nelfinavir; Oxazines; Population Surveillance; Treatment Failure | 2003 |
Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Child; Dideoxynucleosides; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; HIV-1; Humans; Lamivudine; Nelfinavir; Phenotype; RNA, Viral; Zidovudine | 2002 |
Nelfinavir pharmacokinetics in stable human immunodeficiency virus-positive children: Pediatric AIDS Clinical Trials Group Protocol 377.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Antiretroviral Therapy, Highly Active; Biological Availability; Body Weight; Child; Child, Preschool; Dosage Forms; Drug Administration Schedule; HIV Protease Inhibitors; HIV-1; Humans; Infant; Nelfinavir; Nevirapine | 2003 |
A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Alkynes; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; HIV-1; Humans; Indinavir; Male; Nelfinavir; Organophosphonates; Oxazines; Phenotype; Reverse Transcriptase Inhibitors; Treatment Failure | 2003 |
HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Male; Nelfinavir; Phenotype; Stavudine; Treatment Failure; Zidovudine | 2004 |
Pharmacokinetics and pharmacodynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavir.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cell Line; Cell Proliferation; Cyclopropanes; Dideoxynucleosides; Female; HIV-1; Humans; IMP Dehydrogenase; Male; Mycophenolic Acid; Nelfinavir; Oxazines; Viral Load | 2005 |
Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Diarrhea; Drug Therapy, Combination; Female; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Liver; Male; Middle Aged; Nausea; Nelfinavir; Reverse Transcriptase Inhibitors; Saquinavir; Stavudine | 2000 |
Positive impact of protease inhibitors on body composition and energy expenditure in HIV-infected and AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Body Composition; Body Weight; Diet; Drug Therapy, Combination; Energy Intake; Energy Metabolism; Follow-Up Studies; HIV Protease Inhibitors; HIV Seropositivity; Humans; Nelfinavir; Weight Gain | 2000 |
Outcome of a second-line protease inhibitor-containing regimen in patients failing or intolerant of a first highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Protease Inhibitors; HIV Seropositivity; Humans; Male; Nelfinavir; Ritonavir; RNA, Viral; Saquinavir; Time Factors; Treatment Failure; Treatment Outcome | 2000 |
Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Drug Administration Schedule; Humans; Lamivudine; Nelfinavir; Nevirapine; Patient Compliance; Ritonavir; RNA, Viral; Stavudine; Treatment Outcome; Viral Load | 2002 |
36 other study(ies) available for nelfinavir and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amniotic Fluid; Anti-HIV Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Fetal Blood; Genitalia, Female; HIV-1; Humans; Hydrocortisone; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral | 2009 |
Molecular basis for reduced cleavage activity and drug resistance in D30N HIV-1 protease.
Topics: Acquired Immunodeficiency Syndrome; Drug Resistance, Viral; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Mutation; Nelfinavir | 2022 |
New insights into the in silico prediction of HIV protease resistance to nelfinavir.
Topics: Acquired Immunodeficiency Syndrome; Amino Acid Substitution; Drug Resistance, Viral; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Mutation, Missense; Nelfinavir | 2014 |
Analysis of CYP3A4-HIV-1 protease drugs interactions by computational methods for Highly Active Antiretroviral Therapy in HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Computational Biology; Cytochrome P-450 CYP3A; Darunavir; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Nelfinavir; Pyridines; Pyrimidinones; Pyrones; Ritonavir; Sulfonamides | 2010 |
Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adipose Tissue; Adult; Anti-HIV Agents; Blood Glucose; Body Composition; HIV Protease Inhibitors; Homeostasis; Humans; Indinavir; Insulin; Leptin; Lipids; Lipodystrophy; Magnetic Resonance Imaging; Male; Middle Aged; Nelfinavir; Ritonavir; Saquinavir | 2002 |
[No selection of mutations. 908 raises genetic resistance barrier].
Topics: Acquired Immunodeficiency Syndrome; Carbamates; DNA Mutational Analysis; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Furans; HIV Protease; HIV Protease Inhibitors; HIV Reverse Transcriptase; Humans; Nelfinavir; Organophosphates; Sulfonamides; Virus Replication | 2003 |
[A light meal at the same time is enough. Advantages of natural enhancement of nelfinavir].
Topics: Acquired Immunodeficiency Syndrome; Drug Synergism; Drug Therapy, Combination; Food-Drug Interactions; HIV Protease Inhibitors; Humans; Multicenter Studies as Topic; Nelfinavir; Randomized Controlled Trials as Topic; Ritonavir | 2003 |
HIV-1 genotype resistance pattern and evolution in patients failing nelfinavir-containing regimens.
Topics: Acquired Immunodeficiency Syndrome; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Protease Inhibitors; HIV-1; Humans; Male; Mutation; Nelfinavir; Retrospective Studies | 2005 |
Recall of AIDS drug hits world's poorest patients.
Topics: Acquired Immunodeficiency Syndrome; Drug and Narcotic Control; Drug Contamination; Drug Industry; HIV Protease Inhibitors; Humans; Nelfinavir; Poverty | 2007 |
Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Female; Genotype; HIV Reverse Transcriptase; HIV-1; Humans; Lopinavir; Male; Middle Aged; Mutation; Nelfinavir; Nevirapine; Pyrimidinones; Reverse Transcriptase Inhibitors; RNA, Viral; Salvage Therapy | 2007 |
Hundreds enrolled in canadian HIV trials.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Canada; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; HIV Protease Inhibitors; Humans; Isoquinolines; Nelfinavir; Prednisone; Randomized Controlled Trials as Topic; Ritonavir; Sulfonic Acids; Vincristine; Zidovudine | 1997 |
Human immunodeficiency virus type-1 mRNA splicing pattern in infected persons is determined by the proportion of newly infected cells.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; DNA Primers; Drug Therapy, Combination; HIV-1; Humans; Indinavir; Isoquinolines; Leukocytes, Mononuclear; Nelfinavir; Polymerase Chain Reaction; Ritonavir; RNA Splicing; RNA, Messenger; RNA, Viral; Sulfonic Acids; Virus Replication; Zidovudine | 1997 |
Severe diabetes associated with protease inhibitor therapy.
Topics: Acquired Immunodeficiency Syndrome; Diabetes Mellitus; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Male; Middle Aged; Nelfinavir | 1997 |
Drug interactions and protease inhibitor therapy in the treatment of HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Interactions; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Nelfinavir; Patient Education as Topic; Primary Nursing; Ritonavir; Saquinavir | 1998 |
Immune reconstitution in HAART-treated children with AIDS. Highly Active Anti-Retroviral Therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Child; Disease Progression; Female; Follow-Up Studies; Humans; Immunity, Cellular; Immunologic Memory; Lamivudine; Lymphocyte Count; Nelfinavir; Stavudine; Viral Load | 1998 |
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Resistance; Genotype; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Nelfinavir; Phenotype; Polymorphism, Genetic; RNA, Viral | 1998 |
Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Anti-HIV Agents; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Nelfinavir | 1999 |
Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Inflammatory Agents; Antitubercular Agents; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Inflammation; Nelfinavir; Prednisone; Tuberculosis | 1999 |
Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cell Line; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV-1; Humans; Lamivudine; Microbial Sensitivity Tests; Nelfinavir; Phenotype; Salvage Therapy; Time Factors; Transfection; Treatment Failure; Zidovudine | 1999 |
Pharmacokinetic interactions between HIV-protease inhibitors in rats.
Topics: Acquired Immunodeficiency Syndrome; Animals; Drug Interactions; Drug Therapy, Combination; HIV Protease Inhibitors; Indinavir; Male; Nelfinavir; Rats; Rats, Wistar; Ritonavir; Saquinavir | 1999 |
Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Basal Metabolism; Body Composition; Body Weight; Case-Control Studies; Cohort Studies; Didanosine; Energy Metabolism; Female; HIV Infections; HIV Protease Inhibitors; Humans; Longitudinal Studies; Male; Middle Aged; Nelfinavir; Prospective Studies; Stavudine; Viremia | 1999 |
Predictive value of genotypic and phenotypic resistance in 2 nelfinavir-experienced patients.
Topics: Acquired Immunodeficiency Syndrome; Drug Resistance, Microbial; Genotype; HIV Protease Inhibitors; HIV-1; Humans; Nelfinavir; Phenotype | 2000 |
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Resistance, Microbial; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Mutation; Nelfinavir; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Saquinavir; Treatment Failure; Zidovudine | 2001 |
Effects of HIV protease inhibitors on barrier function in the human intestinal cell line HT-29/B6.
Topics: Acquired Immunodeficiency Syndrome; Colon; Diarrhea; HIV Protease Inhibitors; HT29 Cells; Humans; Indinavir; Intestinal Absorption; Intestinal Mucosa; Nelfinavir; Ritonavir; Saquinavir | 2000 |
Nelfinavir study recruiting in eight cities.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Isoquinolines; Multicenter Studies as Topic; Nelfinavir; Sulfonic Acids | 1996 |
Abacavir (1592) with protease inhibitors in potent antiretroviral activity.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Carbamates; Dideoxynucleosides; Drug Therapy, Combination; Furans; HIV Protease Inhibitors; Humans; Indinavir; Nelfinavir; Ritonavir; Saquinavir; Sulfonamides; Viral Load | 1998 |
Nelfinavir produces durable anti-HIV effects for two years.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Humans; Nelfinavir | 1998 |
Nelfinavir failures respond to other protease inhibitors.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Humans; Multicenter Studies as Topic; Nelfinavir; Protease Inhibitors; Treatment Failure | 1998 |
Twice daily dosing study of Viracept.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lamivudine; Nelfinavir; Stavudine | 1998 |
Protease inhibitors and prevention of cross resistance.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Carbamates; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoquinolines; Lamivudine; Nelfinavir; Pyridines; Quinolines; Saquinavir; Sulfonamides; Zalcitabine; Zidovudine | 1995 |
New drug approved to treat HIV.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4 Lymphocyte Count; Child; Clinical Trials as Topic; Diarrhea; Drug Approval; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Nelfinavir; Sulfonic Acids; United States; United States Food and Drug Administration; Viral Load | 1997 |
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Cohort Studies; Drug Administration Schedule; Female; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Male; Middle Aged; Nelfinavir; Nevirapine; Odds Ratio; Patient Compliance; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Saquinavir; Surveys and Questionnaires | 2001 |
Cheap AIDS drugs for developing countries.
Topics: Acquired Immunodeficiency Syndrome; Brazil; Drug Costs; Drug Industry; HIV Protease Inhibitors; Humans; Nelfinavir; South Africa | 2001 |
Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavir.
Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Base Sequence; CD4 Lymphocyte Count; Drug Resistance, Viral; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Molecular Sequence Data; Mutation; Nelfinavir; Reverse Transcriptase Inhibitors; RNA, Viral | 2001 |
Roche gives in to Brazil over AIDS drug.
Topics: Acquired Immunodeficiency Syndrome; Brazil; Drug Industry; Health Policy; HIV Protease Inhibitors; Humans; Nelfinavir | 2001 |
Evolutionary analysis of HIV-1 protease inhibitors: Methods for design of inhibitors that evade resistance.
Topics: Acquired Immunodeficiency Syndrome; Binding Sites; Biological Evolution; Computational Biology; Computer Simulation; Computer-Aided Design; Drug Design; Drug Resistance, Viral; Drug Therapy, Combination; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Models, Molecular; Mutation; Nelfinavir; Ritonavir; Saquinavir | 2002 |